+467.0%
MRNA vs USAR
+13.1%
+454.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | USAR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -3.0% | +8.4% | +5.8% |
| 7D | -1.1% | -11.6% | +10.6% | +0.6% |
| 30D | +126.1% | -15.5% | +141.6% | +131.2% |
| 3M | +190.0% | -31.0% | +221.1% | +202.8% |
| 6M | +157.2% | -26.2% | +183.4% | +161.8% |
| YTD | +388.2% | +30.8% | +357.4% | +351.0% |
| 1Y | +467.0% | +7.1% | +459.9% | +436.4% |
| All | +467.0% | +13.1% | +454.0% | +436.4% |
Cumulative growth
Daily Returns
Daily percentage return beside USAR.
Daily Out/Under-Performance
Portfolio return minus USAR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × USAR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded USAR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling